{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "description": "The Screened Set will include all participants who signed an informed consent form (ICF).",
        "criteria": "Signed an informed consent form"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "description": "The Enrolled Set will include all participants who were enrolled in the study.",
        "criteria": "Enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "description": "The Full Analysis (FA) Set will include all participants who were enrolled and received at least 1 dose of study drug. The FA Set will be the primary population for all efficacy analyses.",
        "criteria": "Enrolled and received at least 1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "The Per Protocol (PP) Set will include all participants in the FA Set who have no major protocol deviations that would impact the primary efficacy endpoint. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint.",
        "criteria": "In FA Set and no major protocol deviations impacting the primary efficacy endpoint"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "description": "The Safety Set will include all participants who received at least 1 dose of study drug. The Safety Set will be used for all safety analyses.",
        "criteria": "Received at least 1 dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "PK",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "The Pharmacokinetic (PK) Analysis Set will include all participants in the Safety Set who have sufficient plasma concentration data to derive at least 1 PK parameter. The PK Analysis Set will be used for all PK analyses.",
        "criteria": "In Safety Set and has sufficient plasma concentration data to derive at least 1 PK parameter"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "description": "The Pharmacodynamic (PD) Analysis Set will include all participants in the Safety Set who have sufficient PD data to derive at least 1 PD parameter. The PD Analysis Set will be used for all PD analyses.",
        "criteria": "In Safety Set and has sufficient PD data to derive at least 1 PD parameter"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age at baseline, summarized as a continuous and categorical variable."
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex at baseline."
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race at baseline."
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity at baseline."
      },
      {
        "id": "char_5",
        "name": "Weight",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Weight at Baseline."
      },
      {
        "id": "char_6",
        "name": "Height",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Height at Baseline."
      },
      {
        "id": "char_7",
        "name": "Body Mass Index (BMI)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body Mass Index (BMI) at Baseline."
      },
      {
        "id": "char_8",
        "name": "Time since initial diagnosis of WD",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Time since initial diagnosis of Wilson Disease in years."
      },
      {
        "id": "char_9",
        "name": "Age at initial diagnosis of WD",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age at initial diagnosis of Wilson Disease in years."
      },
      {
        "id": "char_10",
        "name": "WD cohort",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Wilson Disease cohort (treatment-experienced or treatment-na√Øve)."
      },
      {
        "id": "char_11",
        "name": "Medical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Medical history coded using MedDRA and summarized by system organ class (SOC) and preferred term (PT)."
      },
      {
        "id": "char_12",
        "name": "Surgical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Surgical history coded using MedDRA and summarized by system organ class (SOC) and preferred term (PT)."
      },
      {
        "id": "char_13",
        "name": "WD History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Wilson Disease history summarized by the number and percentage of participants."
      },
      {
        "id": "char_14",
        "name": "Prior medications",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior medications coded using WHO Drug Dictionary and summarized by Anatomical Therapeutic Chemical (ATC) class and preferred term."
      },
      {
        "id": "char_15",
        "name": "Prior medications for WD",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior medications used to treat Wilson Disease, summarized by number and percentage of participants."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 15
    }
  }
}